Summit Therapeutics
SMMT
#1503
Rank
NZ$24.02 B
Marketcap
NZ$32.27
Share price
1.72%
Change (1 day)
0.97%
Change (1 year)

Revenue for Summit Therapeutics (SMMT)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Summit Therapeutics from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A-100%
2022 NZ$1.11 M-58.07%
2021 NZ$2.64 M
2019 NZ$2.15 M-98.13%
2018 NZ$0.11 B229.36%
2017 NZ$34.85 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
NZ$4.18 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
NZ$0.64 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
NZ$0.14 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA